vs
J.Jill, Inc.（JILL）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是J.Jill, Inc.的1.3倍（$197.9M vs $150.5M），REPLIGEN CORP净利率更高（6.7% vs 6.1%，领先0.6%），REPLIGEN CORP同比增速更快（13.6% vs -0.5%），REPLIGEN CORP自由现金流更多（$17.6M vs $16.0M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 0.1%）
J.Jill是1955年创立于美国马萨诸塞州的女装零售品牌，总部位于马萨诸塞州昆西市，自2017年起公开上市，主打面向女性消费者的服饰产品，在美国本土拥有稳定的线下销售网络与客群基础。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
JILL vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$150.5M
营收增速更快
RGEN
高出14.1%
-0.5%
净利率更高
RGEN
高出0.6%
6.1%
自由现金流更多
RGEN
多$1.5M
$16.0M
两年增速更快
RGEN
近两年复合增速
0.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.5M | $197.9M |
| 净利润 | $9.2M | $13.3M |
| 毛利率 | 70.9% | 52.5% |
| 营业利润率 | 9.9% | 9.0% |
| 净利率 | 6.1% | 6.7% |
| 营收同比 | -0.5% | 13.6% |
| 净利润同比 | -25.5% | 143.9% |
| 每股收益（稀释后） | $0.60 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JILLRGEN
| Q4 25 | $150.5M | $197.9M | ||
| Q3 25 | $154.0M | $188.8M | ||
| Q2 25 | $153.6M | $182.4M | ||
| Q1 25 | $142.8M | $169.2M | ||
| Q4 24 | $151.3M | $174.1M | ||
| Q3 24 | $155.2M | $154.9M | ||
| Q2 24 | $161.5M | $154.1M | ||
| Q1 24 | $150.3M | $151.3M |
净利润JILLRGEN
| Q4 25 | $9.2M | $13.3M | ||
| Q3 25 | $10.5M | $14.9M | ||
| Q2 25 | $11.7M | $14.9M | ||
| Q1 25 | $2.2M | $5.8M | ||
| Q4 24 | $12.3M | $-30.3M | ||
| Q3 24 | $8.2M | $-654.0K | ||
| Q2 24 | $16.7M | $3.3M | ||
| Q1 24 | $4.8M | $2.1M |
毛利率JILLRGEN
| Q4 25 | 70.9% | 52.5% | ||
| Q3 25 | 68.4% | 53.2% | ||
| Q2 25 | 71.8% | 50.0% | ||
| Q1 25 | 66.3% | 53.6% | ||
| Q4 24 | 71.4% | 26.1% | ||
| Q3 24 | 70.5% | 50.0% | ||
| Q2 24 | 72.9% | 49.8% | ||
| Q1 24 | 67.5% | 49.5% |
营业利润率JILLRGEN
| Q4 25 | 9.9% | 9.0% | ||
| Q3 25 | 10.9% | 8.9% | ||
| Q2 25 | 12.4% | 7.6% | ||
| Q1 25 | 3.6% | 3.9% | ||
| Q4 24 | 12.7% | -17.7% | ||
| Q3 24 | 14.8% | -5.1% | ||
| Q2 24 | 17.6% | 1.0% | ||
| Q1 24 | 7.0% | 1.3% |
净利率JILLRGEN
| Q4 25 | 6.1% | 6.7% | ||
| Q3 25 | 6.8% | 7.9% | ||
| Q2 25 | 7.6% | 8.2% | ||
| Q1 25 | 1.6% | 3.4% | ||
| Q4 24 | 8.2% | -17.4% | ||
| Q3 24 | 5.3% | -0.4% | ||
| Q2 24 | 10.3% | 2.2% | ||
| Q1 24 | 3.2% | 1.4% |
每股收益（稀释后）JILLRGEN
| Q4 25 | $0.60 | $0.24 | ||
| Q3 25 | $0.69 | $0.26 | ||
| Q2 25 | $0.76 | $0.26 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | $0.80 | $-0.55 | ||
| Q3 24 | $0.54 | $-0.01 | ||
| Q2 24 | $1.16 | $0.06 | ||
| Q1 24 | $0.33 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $58.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $129.0M | $2.1B |
| 总资产 | $458.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资JILLRGEN
| Q4 25 | $58.0M | $767.6M | ||
| Q3 25 | $45.5M | $748.7M | ||
| Q2 25 | $31.2M | $708.9M | ||
| Q1 25 | $35.4M | $697.2M | ||
| Q4 24 | $38.8M | $757.4M | ||
| Q3 24 | $28.5M | $784.0M | ||
| Q2 24 | $77.1M | $809.1M | ||
| Q1 24 | $62.2M | $780.6M |
总债务JILLRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益JILLRGEN
| Q4 25 | $129.0M | $2.1B | ||
| Q3 25 | $121.5M | $2.1B | ||
| Q2 25 | $112.0M | $2.1B | ||
| Q1 25 | $105.8M | $2.0B | ||
| Q4 24 | $103.3M | $2.0B | ||
| Q3 24 | $90.4M | $2.0B | ||
| Q2 24 | $53.1M | $2.0B | ||
| Q1 24 | $37.2M | $2.0B |
总资产JILLRGEN
| Q4 25 | $458.0M | $2.9B | ||
| Q3 25 | $436.5M | $2.9B | ||
| Q2 25 | $432.9M | $2.9B | ||
| Q1 25 | $417.7M | $2.9B | ||
| Q4 24 | $418.3M | $2.8B | ||
| Q3 24 | $390.8M | $2.8B | ||
| Q2 24 | $443.9M | $2.9B | ||
| Q1 24 | $428.2M | $2.8B |
负债/权益比JILLRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 10.6% | 8.9% |
| 资本支出强度资本支出/营收 | 2.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.07× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $37.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流JILLRGEN
| Q4 25 | $19.1M | $25.7M | ||
| Q3 25 | $19.4M | $48.1M | ||
| Q2 25 | $5.3M | $28.6M | ||
| Q1 25 | $8.1M | $15.0M | ||
| Q4 24 | $19.1M | $39.2M | ||
| Q3 24 | $16.4M | $49.3M | ||
| Q2 24 | $21.5M | $42.2M | ||
| Q1 24 | $6.6M | $44.7M |
自由现金流JILLRGEN
| Q4 25 | $16.0M | $17.6M | ||
| Q3 25 | $17.1M | $43.4M | ||
| Q2 25 | $3.1M | $21.5M | ||
| Q1 25 | $1.4M | $11.4M | ||
| Q4 24 | $14.6M | $33.6M | ||
| Q3 24 | $15.0M | $42.3M | ||
| Q2 24 | $19.8M | $37.4M | ||
| Q1 24 | $1.8M | $36.4M |
自由现金流率JILLRGEN
| Q4 25 | 10.6% | 8.9% | ||
| Q3 25 | 11.1% | 23.0% | ||
| Q2 25 | 2.0% | 11.8% | ||
| Q1 25 | 1.0% | 6.8% | ||
| Q4 24 | 9.7% | 19.3% | ||
| Q3 24 | 9.6% | 27.3% | ||
| Q2 24 | 12.2% | 24.3% | ||
| Q1 24 | 1.2% | 24.0% |
资本支出强度JILLRGEN
| Q4 25 | 2.0% | 4.1% | ||
| Q3 25 | 1.5% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 4.7% | 2.1% | ||
| Q4 24 | 2.9% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% | ||
| Q1 24 | 3.2% | 5.5% |
现金转化率JILLRGEN
| Q4 25 | 2.07× | 1.93× | ||
| Q3 25 | 1.84× | 3.23× | ||
| Q2 25 | 0.46× | 1.92× | ||
| Q1 25 | 3.60× | 2.57× | ||
| Q4 24 | 1.54× | — | ||
| Q3 24 | 2.00× | — | ||
| Q2 24 | 1.29× | 12.70× | ||
| Q1 24 | 1.39× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JILL
| Sales Channel Through Intermediary | $80.1M | 53% |
| Sales Channel Directly To Consumer | $70.5M | 47% |
RGEN
暂无分部数据
